BioTuesdays

Category - Markets

Verastem
Markets

BTIG cuts Verastem to Neutral; PT removed

BTIF downgraded Verastem (NASDAQ:VSTM) to “neutral” from “buy” and removed its previous price target of $8 after the company announced that president and CEO, Robert Forrester, was stepping down. The stock closed at $1...

June 20, 2019
Markets

SVB Leerink ups Provention Bio PT to $17 from $5.50

SVB Leerink raised its price target for Provention Bio (NASDAQ:PRVB) to $17 from $5.50, following positive At-Risk trial results presented at the American Diabetes Association meeting last week. The stock closed at $11...

June 18, 2019
ReWalk Robotics
Markets

HCW ups ReWalk Robotics to buy; PT to $9

H.C. Wainwright upgraded ReWalk Robotics (NASDAQ:RWLK) to “buy” from “neutral” and raised its price target to $9 from $4, citing several key milestones in the past few months. The stock closed at $5.21 on June 14.

June 17, 2019
Tetraphase Pharmaceuticals
Markets

HCW cuts Tetraphase Pharma PT to $1.50 from $7

H.C. Wainwright slashed its price target for Tetraphase Pharmaceuticals (NASDAQ:TTPH) to $1.50 from $7 after the company unveiled a sweeping corporate reorganization. The stock closed at 74 cents on June 12.

June 13, 2019